Trials / Completed
CompletedNCT00000235
Alternate Day Buprenorphine Administration, Phase XII - 17
Alternate Day Buprenorphine Administration, Phase XII
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if six times daily buprenorphine dose is effective in achieving 120 hour buprenorphine dosing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine |
Timeline
- First posted
- 1999-09-21
- Last updated
- 2005-08-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000235. Inclusion in this directory is not an endorsement.